RNA Based Therapeutics Market Size, Share, Trends, Growth 2032
RNA Based Therapeutics Market By Technology (Enabled Technology and Enabling Technology), By Application (Kidney Diseases, Cardiovascular, Metabolic Disorders, Infectious Diseases, Oncology, and Others), and By End-User (Research, Diagnosis, Therapeutics, and Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 13.66 Billion | USD 24.07 Billion | 6.50% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global RNA Based Therapeutics Market, 2016-2025 (USD Billion)
- 2.2. Global RNA Based Therapeutics Market: Snapshot
- Chapter 3. RNA Based Therapeutics Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global RNA Based Therapeutics Market drivers: Impact analysis
- 3.2.2. Target specificity and selectivity of treatment
- 3.2.3. Favorable Government Funding/Grant for R&D
- 3.3. MarketRestraints
- 3.3.1. High R&D Cost
- 3.4. Opportunities
- 3.4.1. Emerging Markets
- 3.5. Porter's Five Forces Analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Technology
- 3.6.2. Market attractiveness analysis, by Application
- 3.6.3. Market attractiveness analysis, by End-User
- 3.6.4. Market attractiveness analysis, by Region
- Chapter 4. Global RNA Based Therapeutics Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global RNA Based Therapeutics Market: Company Market Share, 2018
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Application Launch
- 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
- 4.2.4. Research and Development and Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global RNA Based Therapeutics Market - Technology Analysis
- 5.1. Global RNA Based Therapeutics Market: Technology overview
- 5.1.1. Global RNA Based Therapeutics Market revenue share, by Technology, 2018 and 2025
- 5.2. Enabled Technology
- 5.2.1. Global RNA Based Therapeutics Market for Enabled Technology, 2016-2025 (USD Billion)
- 5.3. Enabling Technology
- 5.3.1. Global RNA Based Therapeutics Market for Enabling Technology, 2016-2025 (USD Billion)
- 5.1. Global RNA Based Therapeutics Market: Technology overview
- Chapter 6. Global RNA Based Therapeutics Market - Application Analysis
- 6.1. Global RNA Based Therapeutics Market: Application segment overview
- 6.1.1. Global RNA Based Therapeutics Market revenue share, by Application, 2018 and 2025
- 6.2. Cardiovascular
- 6.2.1. Global RNA Based Therapeutics Market for Cardiovascular, 2016-2025 (USD Billion)
- 6.3. Kidney Diseases
- 6.3.1. Global RNA Based Therapeutics Market for Kidney Diseases, 2016-2025 (USD Billion)
- 6.4. Oncology
- 6.4.1. Global RNA Based Therapeutics Market for Oncology, 2016-2025 (USD Billion)
- 6.5. Infectious Diseases
- 6.5.1. Global RNA Based Therapeutics Market for Infectious Diseases, 2016-2025 (USD Billion)
- 6.6. Metabolic Disorders
- 6.6.1. Global RNA Based Therapeutics Market for Metabolic disorders, 2016-2025 (USD Billion)
- 6.7. Others
- 6.7.1. Global RNA Based Therapeutics Market for Others, 2016-2025 (USD Billion)
- 6.1. Global RNA Based Therapeutics Market: Application segment overview
- Chapter 7. Global RNA Based Therapeutics Market - End-User Analysis
- 7.1. Global RNA Based Therapeutics Market: End-User overview
- 7.1.1. Global RNA Based Therapeutics Market revenue share, by End-User, 2018 and 2025
- 7.2. Research
- 7.2.1. Global RNA Based Therapeutics Market for Research, 2016-2025 (USD Billion)
- 7.3. Therapeutics
- 7.3.1. Global RNA Based Therapeutics Market for Therapeutics, 2016-2025 (USD Billion)
- 7.4. Diagnosis
- 7.4.1. Global RNA Based Therapeutics Market for Diagnosis, 2016-2025 (USD Billion)
- 7.5. Others
- 7.5.1. Global RNA Based Therapeutics Market for Others, 2016-2025 (USD Billion)
- 7.1. Global RNA Based Therapeutics Market: End-User overview
- Chapter 8. Global RNA Based Therapeutics Market - Regional Analysis
- 8.1. Global RNA Based Therapeutics Market: Regional overview
- 8.1.1. Global RNA Based Therapeutics Market revenue share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.2.2. North America RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.2.3. North America RNA Based Therapeutics Market revenue, by End-User, 2016-2025 (USD Billion)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.2.4.2. The U.S. RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.2.4.3. The U.S. RNA Based Therapeutics Market revenue, by End-User, 2016-2025 (USD Billion)
- 8.2.5. Rest of North America
- 8.2.5.1. Rest of North America RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.2.5.2. Rest of North America RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.2.5.3. Rest of North America RNA Based Therapeutics Market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.3.2. Europe RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.3.3. Europe RNA Based Therapeutics Market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.4. Germany
- 8.3.4.1. Germany RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.3.4.2. Germany RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.3.4.3. Germany RNA Based Therapeutics Market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.5. UK
- 8.3.5.1. UK RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.3.5.2. UK RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.3.5.3. UK RNA Based Therapeutics Market Revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.6. France
- 8.3.6.1. France RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.3.6.2. France RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.3.6.3. France RNA Based Therapeutics Market Revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.3.7.2. Rest of Europe RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.3.7.3. Rest of Europe RNA Based Therapeutics Market Revenue, by End-User, 2016-2025 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.4.2. Asia Pacific RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.4.3. Asia Pacific RNA Based Therapeutics Market Revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.4. China
- 8.4.4.1. China RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.4.4.2. China RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.4.4.3. China RNA Based Therapeutics Market Revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.5. Japan
- 8.4.5.1. Japan RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.4.5.2. Japan RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.4.5.3. Japan RNA Based Therapeutics Market Revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.6. India
- 8.4.6.1. India RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.4.6.2. India RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.4.6.3. India RNA Based Therapeutics Market Revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.4.7.2. Rest of Asia Pacific RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.4.7.3. Rest of Asia Pacific RNA Based Therapeutics Market Revenue, by End-User, 2016-2025 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.5.2. Latin America RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.5.3. Latin America RNA Based Therapeutics Market revenue, by End-User, 2016-2025 (USD Billion)
- 8.5.4. Brazil
- 8.5.4.1. Brazil RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.5.4.2. Brazil RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.5.4.3. Brazil RNA Based Therapeutics Market revenue, by End-User, 2016-2025 (USD Billion)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.5.5.2. Rest of Latin America RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.5.5.3. Rest of Latin America RNA Based Therapeutics Market revenue, by End-User, 2016-2025 (USD Billion)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa RNA Based Therapeutics Market Revenue, by Technology, 2016-2025 (USD Billion)
- 8.6.2. The Middle East and Africa RNA Based Therapeutics Market Revenue, by Application, 2016-2025 (USD Billion)
- 8.6.3. The Middle East and Africa RNA Based Therapeutics Market revenue, by End-User, 2016-2025 (USD Billion)
- 8.1. Global RNA Based Therapeutics Market: Regional overview
- Chapter 9. Company Profile
- 9.1. Quark Pharmaceuticals
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Therapy portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Alnylam Pharmaceuticals
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Therapy portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Dicerna Pharmaceuticals
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Therapy portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Tekmira Pharmaceuticals
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Therapy portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Benitec Biopharma
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Therapy portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. Genzyme Corporation
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Therapy portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. Ionis Pharmaceuticals
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Therapy portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Silence Therapeutics
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Therapy portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. Cenix BioScience
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Therapy portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Sirnaomics
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Therapy portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.1. Quark Pharmaceuticals
Table Of Figures
List of Figures
1. Market research application
2. Market research methodology
3. Global RNA Based Therapeutics Market, 2016–2025 (USD Billion)
4. Porter’s five forces analysis
5. RNA Based Therapeutics Market attractiveness analysis, by Technology
6. RNA Based Therapeutics Market attractiveness analysis, by Application
7. RNA Based Therapeutics Market attractiveness analysis, by End-User
8. RNA Based Therapeutics Market attractiveness analysis, by Region
9. Company market share analysis, 2018
10. Global RNA Based Therapeutics Market revenue share by Technology, 2018 and 2025
11. Global RNA Based Therapeutics Market for Enabling technology, 2016–2025 (USD Billion)
12. Global RNA Based Therapeutics Market for Enabled technology, 2016–2025 (USD Billion)
13. Global RNA Based Therapeutics Market revenue share by Application, 2018 and 2025
14. Global RNA Based Therapeutics Market for Cardiovascular, 2016–2025 (USD Billion)
15. Global RNA Based Therapeutics Market for Kidney Diseases, 2016–2025 (USD Billion)
16. Global RNA Based Therapeutics Market for Oncology, 2016–2025 (USD Billion)
17. Global RNA Based Therapeutics Market for Infectious Diseases, 2016–2025 (USD Billion)
18. Global RNA Based Therapeutics Market for Metabolic disorders, 2016–2025 (USD Billion)
19. Global RNA Based Therapeutics Market for Others, 2016–2025 (USD Billion)
20. Global RNA Based Therapeutics Market revenue share by End-User, 2018 and 2025
21. Global RNA Based Therapeutics Market for Research, 2016–2025 (USD Billion)
22. Global RNA Based Therapeutics Market for Therapeutics, 2016–2025 (USD Billion)
23. Global RNA Based Therapeutics Market for Diagnosis, 2016–2025 (USD Billion)
24. Global RNA Based Therapeutics Market for Others, 2016–2025 (USD Billion)
25. North America RNA Based Therapeutics Market, 2016–2025 (USD Billion)
26. Europe RNA Based Therapeutics Market, 2016–2025 (USD Billion)
27. Asia Pacific RNA Based Therapeutics Market, 2016–2025 (USD Billion)
28. Latin America RNA Based Therapeutics Market, 2016–2025 (USD Billion)
29. The Middle East and Africa RNA Based Therapeutics Market, 2016–2025 (USD Billion)
Table Of Tables
List of Tables
1. RNA Based Therapeutics Market: Market Snapshot
2. Drivers of the Global RNA Based Therapeutics Market: Impact analysis
3. Restraints of the Global RNA Based Therapeutics Market: Impact analysis
4. North America RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
5. North America RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
6. North America RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
7. The U.S. RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
8. The U.S. RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
9. The U.S. RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
10. Rest of North America RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
11. Rest of North America RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
12. Rest of North America RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
13. Europe RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
14. Europe RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
15. Europe RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
16. Germany RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
17. Germany RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
18. Germany RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
19. U.K. RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
20. U.K. RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
21. U.K. RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
22. France RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
23. France RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
24. France RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
25. Rest of Europe RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
26. Rest of Europe RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
27. Rest of Europe RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
28. Asia Pacific RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
29. Asia Pacific RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
30. Asia Pacific RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
31. China RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
32. China RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
33. China RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
34. Japan RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
35. Japan RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
36. Japan RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
37. India RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
38. India RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
39. India RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
40. Rest of Asia Pacific RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
41. Rest of Asia Pacific RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
42. Rest of Asia Pacific RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
43. Latin America RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
44. Latin America RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
45. Latin America RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
46. Brazil RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
47. Brazil RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
48. Brazil RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
49. Rest of Latin America RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
50. Rest of Latin America RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
51. Rest of Latin America RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
52. The Middle East and Africa RNA Based Therapeutics Market Revenue, by Technology, 2016–2025 (USD Billion)
53. The Middle East and Africa RNA Based Therapeutics Market Revenue, by Application, 2016–2025 (USD Billion)
54. The Middle East and Africa RNA Based Therapeutics Market Revenue, by End-User, 2016–2025 (USD Billion)
Methodology
FrequentlyAsked Questions
RNA-based therapeutics comprise a category of drugs that target the treatment or prevention of disease by modulating gene expression or protein function within cells via ribonucleic acid (RNA) molecules. A variety of RNA molecules, including messenger RNA (mRNA), small interfering RNA (siRNA), microRNA (miRNA), and antisense oligonucleotides (ASOs), are utilized in therapeutic applications. Therapeutic applications and mechanisms of action vary among different types of RNA molecules.
Continuous progress in the fields of RNA synthesis, delivery, and modification improves the safety, specificity, and effectiveness of therapeutics based on RNA. By expanding the therapeutic potential of RNA-based pharmaceuticals, innovations such as lipid nanoparticles for delivery, chemically modified RNA molecules for stability, and CRISPR-based RNA editing techniques stimulate market expansion.
The global rna based therapeutics market size was worth around USD 13.66 billion in 2023 and is predicted to grow to around USD 24.07 billion by 2032.
The global rna based therapeutics market with a compound annual growth rate (CAGR) of roughly 6.50% between 2024 and 2032.
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some key players in RNA based therapeutics market include Quark Pharmaceuticals, Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Tekmira Pharmaceuticals, Benitec Biopharma, Genzyme Corporation, Ionis Pharmaceuticals, Silence Therapeutics, Cenix BioScience, and Sirnaomics.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed